Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of WHO-Recommended and Higher Dosage of Levofloxacin in Children with Tuberculosis
TCTR20190515001Phase 4Completed
- Sponsor
- Center of Excellence for Pediatric Infectious Diseases and Vaccines
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of levofloxacin in Tuberculosis (TB) (2 arms), sponsored by Center of Excellence for Pediatric Infectious Diseases and Vaccines. Started Jun 2019; status: completed.
02
Drugs
levofloxacin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on TCTR20190515001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190515001.